Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum—A randomized clinical trial
Author:
Affiliation:
1. Department of Dermatology, Venereology, and Leprology Postgraduate Institute of Medical Education and Research Chandigarh India
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15125
Reference23 articles.
1. Epidemiological Characteristics of Leprosy Reactions: 15 Years Experience from North India1
2. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum
3. Organization WH. WHO Guidelines for the Management of Severe Erythema Nodosum Leprosum (ENL) Reactions. World Health Organization.2015.
4. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition
5. Minocycline for Recurrent and/or Chronic Erythema Nodosum Leprosum
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs;International Journal of Dermatology;2024-09-11
2. Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis;Journal of Infection;2023-04
3. Beneficial Effect of Minocycline as Additional Treatment to Prednisone for Pustular Erythema Nodosum Leprosum;International Medical Case Reports Journal;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3